{"id":10179,"date":"2024-04-11T10:18:02","date_gmt":"2024-04-11T08:18:02","guid":{"rendered":"https:\/\/www.joffeassocies.com\/?p=10179"},"modified":"2024-04-11T10:18:02","modified_gmt":"2024-04-11T08:18:02","slug":"boydsense-increases-its-capital-by-7-million-euros","status":"publish","type":"post","link":"https:\/\/www.joffeassocies.com\/en\/boydsense-increases-its-capital-by-7-million-euros\/","title":{"rendered":"BOYDSense increases its capital by 7 million euros"},"content":{"rendered":"<p style=\"text-align: justify;\">Read the full article on the BOYDSense website <a href=\"https:\/\/www.boydsense.com\/boydsense-raises-e7m-in-a-capital-increase-to-further-develop-its-non-invasive-glucose-monitoring-device\/\">here<\/a>.<\/p>\n<p>&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Medical device company <a href=\"https:\/\/www.boydsense.com\/\">BOYDSense<\/a> has carried out a \u20ac7 million capital increase to support the development of its non-invasive glucose monitoring solutions. <a href=\"https:\/\/www.joffeassocies.com\/en\/\">Joffe &amp; Associ\u00e9s<\/a> (<a href=\"https:\/\/www.joffeassocies.com\/en\/avocat\/thomas-saltiel\/\">Thomas Saltiel<\/a>, <a href=\"https:\/\/www.joffeassocies.com\/en\/avocat\/charlotte-viandaz\/\">Charlotte Viandaz<\/a> and <a href=\"https:\/\/www.joffeassocies.com\/en\/avocat\/remi-rodriguez-joffe-associes\/\">R\u00e9mi Rodriguez<\/a>) advised BOYDSense and its historical investors, <a href=\"https:\/\/www.jolt-capital.com\/\">Jolt Capital<\/a> and <a href=\"https:\/\/www.ambrosiainv.com\/\">Ambrosia Investments Group<\/a>, on this transaction.<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p style=\"text-align: justify;\">Alpha MOS&#8217;s medical technology (&#8216;medtech&#8217;) division closes a seven million euro capital increase, including 1.5 million euros from the conversion of convertible bonds, and 5.5 million euros in additional cash. The capital increase was carried out by a group of investors led by the Swiss Diabetes Venture Fund and Bioserenity, with the participation of the European Innovation Council&#8217;s EIC Fund. Alpha MOS&#8217;s two long-standing shareholders, Jolt Capital and Ambrosia Investments, are also participating in this transaction, through the conversion of convertible bonds they subscribed to in 2023.<\/p>\n<p>&nbsp;<\/p>\n<p style=\"text-align: justify;\">With this capital increase, BOYDSense aims to accelerate the development of its non-invasive glucose measurement device for people with diabetes and pre-diabetes. The funds raised will enable the company to launch new clinical studies, set up the quality procedures needed to obtain the certifications required &#8211; notably ISO 13485 &#8211; for future market authorization, pursue miniaturization and recruit key positions, while ensuring financial autonomy until 2025.<\/p>\n<p>&nbsp;<\/p>\n<blockquote><p>In the Boydsense press release, company director Ben Delhey explains that; &#8220;These new investors bring BOYDSense both significant financial resources and valuable new skills and expertise. They complement the know-how and immense contribution of the BOYDSense team, whom I would like to congratulate on all the milestones we have already achieved&#8221;.<\/p>\n<p>&nbsp;<\/p><\/blockquote>\n<p style=\"text-align: justify;\">According to Fortuneo Banque, after this operation, Alpha MOS will remain the majority shareholder with over 60% of BOYDSense&#8217;s capital.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Read the full article on the BOYDSense website here. &nbsp; Medical device company BOYDSense has carried out a \u20ac7 million capital increase to support the development of its non-invasive glucose monitoring solutions. Joffe &amp; Associ\u00e9s (Thomas Saltiel, Charlotte Viandaz and R\u00e9mi Rodriguez) advised BOYDSense and its historical investors, Jolt Capital and Ambrosia Investments Group, on [&hellip;]<\/p>\n","protected":false},"author":7,"featured_media":10132,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[12],"tags":[],"class_list":["post-10179","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-deals-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v22.4 (Yoast SEO v27.0) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>BOYDSense increases its capital by 7 million euros<\/title>\n<meta name=\"description\" content=\"Medical device company BOYDSense has carried out a \u20ac7 million capital increase to support the development of its non-invasive glucose monitoring solutions.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.joffeassocies.com\/en\/boydsense-increases-its-capital-by-7-million-euros\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BOYDSense increases its capital by 7 million euros\" \/>\n<meta property=\"og:description\" content=\"Medical device company BOYDSense has carried out a \u20ac7 million capital increase to support the development of its non-invasive glucose monitoring solutions.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.joffeassocies.com\/en\/boydsense-increases-its-capital-by-7-million-euros\/\" \/>\n<meta property=\"og:site_name\" content=\"Joffe &amp; Associ\u00e9s\" \/>\n<meta property=\"article:published_time\" content=\"2024-04-11T08:18:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.joffeassocies.com\/wp-content\/uploads\/2024\/04\/Boydsense-avril-2024-site.png\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"348\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Valentin Poitou\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@JoffeAssocies\" \/>\n<meta name=\"twitter:site\" content=\"@JoffeAssocies\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Valentin Poitou\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.joffeassocies.com\/en\/boydsense-increases-its-capital-by-7-million-euros\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.joffeassocies.com\/en\/boydsense-increases-its-capital-by-7-million-euros\/\"},\"author\":{\"name\":\"Valentin Poitou\",\"@id\":\"https:\/\/www.joffeassocies.com\/#\/schema\/person\/e5592630e308ed4af81e692625cca7bc\"},\"headline\":\"BOYDSense increases its capital by 7 million euros\",\"datePublished\":\"2024-04-11T08:18:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.joffeassocies.com\/en\/boydsense-increases-its-capital-by-7-million-euros\/\"},\"wordCount\":291,\"image\":{\"@id\":\"https:\/\/www.joffeassocies.com\/en\/boydsense-increases-its-capital-by-7-million-euros\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.joffeassocies.com\/wp-content\/uploads\/2024\/04\/Boydsense-avril-2024-site.png\",\"articleSection\":[\"Deals\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.joffeassocies.com\/en\/boydsense-increases-its-capital-by-7-million-euros\/\",\"url\":\"https:\/\/www.joffeassocies.com\/en\/boydsense-increases-its-capital-by-7-million-euros\/\",\"name\":\"BOYDSense increases its capital by 7 million euros\",\"isPartOf\":{\"@id\":\"https:\/\/www.joffeassocies.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.joffeassocies.com\/en\/boydsense-increases-its-capital-by-7-million-euros\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.joffeassocies.com\/en\/boydsense-increases-its-capital-by-7-million-euros\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.joffeassocies.com\/wp-content\/uploads\/2024\/04\/Boydsense-avril-2024-site.png\",\"datePublished\":\"2024-04-11T08:18:02+00:00\",\"author\":{\"@id\":\"https:\/\/www.joffeassocies.com\/#\/schema\/person\/e5592630e308ed4af81e692625cca7bc\"},\"description\":\"Medical device company BOYDSense has carried out a \u20ac7 million capital increase to support the development of its non-invasive glucose monitoring solutions.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.joffeassocies.com\/en\/boydsense-increases-its-capital-by-7-million-euros\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.joffeassocies.com\/en\/boydsense-increases-its-capital-by-7-million-euros\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.joffeassocies.com\/en\/boydsense-increases-its-capital-by-7-million-euros\/#primaryimage\",\"url\":\"https:\/\/www.joffeassocies.com\/wp-content\/uploads\/2024\/04\/Boydsense-avril-2024-site.png\",\"contentUrl\":\"https:\/\/www.joffeassocies.com\/wp-content\/uploads\/2024\/04\/Boydsense-avril-2024-site.png\",\"width\":800,\"height\":348},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.joffeassocies.com\/en\/boydsense-increases-its-capital-by-7-million-euros\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.joffeassocies.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BOYDSense increases its capital by 7 million euros\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.joffeassocies.com\/#website\",\"url\":\"https:\/\/www.joffeassocies.com\/\",\"name\":\"Joffe &amp; Associ\u00e9s\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.joffeassocies.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.joffeassocies.com\/#\/schema\/person\/e5592630e308ed4af81e692625cca7bc\",\"name\":\"Valentin Poitou\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.joffeassocies.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/747f77ed431582465814b5606637910b42405f7eb0063e215b2f68990a7befab?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/747f77ed431582465814b5606637910b42405f7eb0063e215b2f68990a7befab?s=96&d=mm&r=g\",\"caption\":\"Valentin Poitou\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"BOYDSense increases its capital by 7 million euros","description":"Medical device company BOYDSense has carried out a \u20ac7 million capital increase to support the development of its non-invasive glucose monitoring solutions.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.joffeassocies.com\/en\/boydsense-increases-its-capital-by-7-million-euros\/","og_locale":"en_US","og_type":"article","og_title":"BOYDSense increases its capital by 7 million euros","og_description":"Medical device company BOYDSense has carried out a \u20ac7 million capital increase to support the development of its non-invasive glucose monitoring solutions.","og_url":"https:\/\/www.joffeassocies.com\/en\/boydsense-increases-its-capital-by-7-million-euros\/","og_site_name":"Joffe &amp; Associ\u00e9s","article_published_time":"2024-04-11T08:18:02+00:00","og_image":[{"width":800,"height":348,"url":"https:\/\/www.joffeassocies.com\/wp-content\/uploads\/2024\/04\/Boydsense-avril-2024-site.png","type":"image\/png"}],"author":"Valentin Poitou","twitter_card":"summary_large_image","twitter_creator":"@JoffeAssocies","twitter_site":"@JoffeAssocies","twitter_misc":{"Written by":"Valentin Poitou","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.joffeassocies.com\/en\/boydsense-increases-its-capital-by-7-million-euros\/#article","isPartOf":{"@id":"https:\/\/www.joffeassocies.com\/en\/boydsense-increases-its-capital-by-7-million-euros\/"},"author":{"name":"Valentin Poitou","@id":"https:\/\/www.joffeassocies.com\/#\/schema\/person\/e5592630e308ed4af81e692625cca7bc"},"headline":"BOYDSense increases its capital by 7 million euros","datePublished":"2024-04-11T08:18:02+00:00","mainEntityOfPage":{"@id":"https:\/\/www.joffeassocies.com\/en\/boydsense-increases-its-capital-by-7-million-euros\/"},"wordCount":291,"image":{"@id":"https:\/\/www.joffeassocies.com\/en\/boydsense-increases-its-capital-by-7-million-euros\/#primaryimage"},"thumbnailUrl":"https:\/\/www.joffeassocies.com\/wp-content\/uploads\/2024\/04\/Boydsense-avril-2024-site.png","articleSection":["Deals"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.joffeassocies.com\/en\/boydsense-increases-its-capital-by-7-million-euros\/","url":"https:\/\/www.joffeassocies.com\/en\/boydsense-increases-its-capital-by-7-million-euros\/","name":"BOYDSense increases its capital by 7 million euros","isPartOf":{"@id":"https:\/\/www.joffeassocies.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.joffeassocies.com\/en\/boydsense-increases-its-capital-by-7-million-euros\/#primaryimage"},"image":{"@id":"https:\/\/www.joffeassocies.com\/en\/boydsense-increases-its-capital-by-7-million-euros\/#primaryimage"},"thumbnailUrl":"https:\/\/www.joffeassocies.com\/wp-content\/uploads\/2024\/04\/Boydsense-avril-2024-site.png","datePublished":"2024-04-11T08:18:02+00:00","author":{"@id":"https:\/\/www.joffeassocies.com\/#\/schema\/person\/e5592630e308ed4af81e692625cca7bc"},"description":"Medical device company BOYDSense has carried out a \u20ac7 million capital increase to support the development of its non-invasive glucose monitoring solutions.","breadcrumb":{"@id":"https:\/\/www.joffeassocies.com\/en\/boydsense-increases-its-capital-by-7-million-euros\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.joffeassocies.com\/en\/boydsense-increases-its-capital-by-7-million-euros\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.joffeassocies.com\/en\/boydsense-increases-its-capital-by-7-million-euros\/#primaryimage","url":"https:\/\/www.joffeassocies.com\/wp-content\/uploads\/2024\/04\/Boydsense-avril-2024-site.png","contentUrl":"https:\/\/www.joffeassocies.com\/wp-content\/uploads\/2024\/04\/Boydsense-avril-2024-site.png","width":800,"height":348},{"@type":"BreadcrumbList","@id":"https:\/\/www.joffeassocies.com\/en\/boydsense-increases-its-capital-by-7-million-euros\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.joffeassocies.com\/en\/"},{"@type":"ListItem","position":2,"name":"BOYDSense increases its capital by 7 million euros"}]},{"@type":"WebSite","@id":"https:\/\/www.joffeassocies.com\/#website","url":"https:\/\/www.joffeassocies.com\/","name":"Joffe &amp; Associ\u00e9s","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.joffeassocies.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.joffeassocies.com\/#\/schema\/person\/e5592630e308ed4af81e692625cca7bc","name":"Valentin Poitou","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.joffeassocies.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/747f77ed431582465814b5606637910b42405f7eb0063e215b2f68990a7befab?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/747f77ed431582465814b5606637910b42405f7eb0063e215b2f68990a7befab?s=96&d=mm&r=g","caption":"Valentin Poitou"}}]}},"_links":{"self":[{"href":"https:\/\/www.joffeassocies.com\/en\/wp-json\/wp\/v2\/posts\/10179","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.joffeassocies.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.joffeassocies.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.joffeassocies.com\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.joffeassocies.com\/en\/wp-json\/wp\/v2\/comments?post=10179"}],"version-history":[{"count":2,"href":"https:\/\/www.joffeassocies.com\/en\/wp-json\/wp\/v2\/posts\/10179\/revisions"}],"predecessor-version":[{"id":10182,"href":"https:\/\/www.joffeassocies.com\/en\/wp-json\/wp\/v2\/posts\/10179\/revisions\/10182"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.joffeassocies.com\/en\/wp-json\/wp\/v2\/media\/10132"}],"wp:attachment":[{"href":"https:\/\/www.joffeassocies.com\/en\/wp-json\/wp\/v2\/media?parent=10179"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.joffeassocies.com\/en\/wp-json\/wp\/v2\/categories?post=10179"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.joffeassocies.com\/en\/wp-json\/wp\/v2\/tags?post=10179"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}